-
11.
公开(公告)号:CA2368823A1
公开(公告)日:2000-11-16
申请号:CA2368823
申请日:2000-04-28
Applicant: BASF AG
Inventor: GROSS GERHARD , STARCK DOROTHEA , MUHLBAUER BERND , TREIBER HANS-JORG
IPC: C07D241/04 , A61K31/00 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5513 , A61K45/00 , A61P1/00 , A61P13/12 , C07D401/12 , C07D403/12
Abstract: The invention relates to the use of dopamine D3 receptor ligands for produci ng medicaments for treating kidney disorders.
-
12.
公开(公告)号:HRP20010472A2
公开(公告)日:2003-04-30
申请号:HRP20010472
申请日:2001-06-21
Applicant: BASF AG
Inventor: MUNSCHAUER RAINER , GROSS GERHARD , TRAUT MARTIN , UNGER LILIANE , TESCHENDORF HANS-JUERGEN
IPC: C07D403/06 , A61K31/403 , A61K31/4045 , A61K31/407 , A61K31/4184 , A61K31/424 , A61K31/427 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/542 , A61P25/00 , A61P25/28 , A61P25/30 , A61P25/36 , C07D209/52 , C07D407/12 , C07D409/12 , C07D417/06 , C07D471/04 , C07D498/04 , C07D513/04 , A61K31/416 , A61K31/428 , A61K31/538
Abstract: The invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I), wherein B, R , R and n have the meanings given in the description, for combating diseases of addiction and other diseases of the central nervous system.
-
公开(公告)号:NO20015413L
公开(公告)日:2001-11-15
申请号:NO20015413
申请日:2001-11-06
Applicant: BASF AG
Inventor: MUEHLBAUER BERND , GROSS GERHARD , STARCK DOROTHEA , TREIBER HANS-JOERG
IPC: C07D241/04 , A61K31/00 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5513 , A61K45/00 , A61P1/00 , A61P13/12 , C07D401/12 , C07D403/12 , A61K31/4196
Abstract: The invention relates to the use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders.
-
公开(公告)号:NO20015413A
公开(公告)日:2001-11-15
申请号:NO20015413
申请日:2001-11-06
Applicant: BASF AG
Inventor: MUEHLBAUER BERND , GROSS GERHARD , STARCK DOROTHEA , TREIBER HANS-JOERG
IPC: C07D241/04 , A61K31/00 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5513 , A61K45/00 , A61P1/00 , A61P13/12 , C07D401/12 , C07D403/12 , A61K31/4196
CPC classification number: A61K31/517 , A61K31/00 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/506
-
公开(公告)号:NO20015413D0
公开(公告)日:2001-11-06
申请号:NO20015413
申请日:2001-11-06
Applicant: BASF AG
Inventor: MUEHLBAUER BERND , GROSS GERHARD , STARCK DOROTHEA , TREIBER HANS-JOERG
IPC: C07D241/04 , A61K31/00 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5513 , A61K45/00 , A61P1/00 , A61P13/12 , C07D401/12 , C07D403/12 , A61P
Abstract: The invention relates to the use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders.
-
公开(公告)号:TR200101476T2
公开(公告)日:2001-10-22
申请号:TR200101476
申请日:1999-11-12
Applicant: BASF AG
Inventor: MUNSCHAUER RAINER , STEINER GERD , GROSS GERHARD , TRAUT MARTIN , UNGER LILIANE , TESCHENDORF HANS-JUERGEN
IPC: C07D403/06 , A61K31/403 , A61K31/4045 , A61K31/407 , A61K31/4184 , A61K31/424 , A61K31/427 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/542 , A61P25/00 , A61P25/28 , A61P25/30 , A61P25/36 , C07D209/52 , C07D407/12 , C07D409/12 , C07D417/06 , C07D471/04 , C07D498/04 , C07D513/04
Abstract: The invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I), wherein B, R , R and n have the meanings given in the description, for combating diseases of addiction and other diseases of the central nervous system.
-
公开(公告)号:NO20012538L
公开(公告)日:2001-07-04
申请号:NO20012538
申请日:2001-05-23
Applicant: BASF AG
Inventor: MUNSCHAUER RAINER , STEINER GERD , GROSS GERHARD , TRAUT MARTIN , UNGER LILIANE , TESCHENDORF HANS-JUERGEN
IPC: C07D403/06 , A61K31/403 , A61K31/4045 , A61K31/407 , A61K31/4184 , A61K31/424 , A61K31/427 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/542 , A61P25/00 , A61P25/28 , A61P25/30 , A61P25/36 , C07D209/52 , C07D407/12 , C07D409/12 , C07D417/06 , C07D471/04 , C07D498/04 , C07D513/04 , A61K31/416 , A61K31/428 , A61K31/538
Abstract: The invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I), wherein B, R , R and n have the meanings given in the description, for combating diseases of addiction and other diseases of the central nervous system.
-
18.
公开(公告)号:CA2352526A1
公开(公告)日:2000-06-02
申请号:CA2352526
申请日:1999-11-12
Applicant: BASF AG
Inventor: STEINER GERD , MUNSCHAUER RAINER , GROSS GERHARD , UNGER LILIANE , TRAUT MARTIN , TESCHENDORF HANS-JURGEN
IPC: C07D403/06 , A61K31/403 , A61K31/4045 , A61K31/407 , A61K31/4184 , A61K31/424 , A61K31/427 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/542 , A61P25/00 , A61P25/28 , A61P25/30 , A61P25/36 , C07D209/52 , C07D407/12 , C07D409/12 , C07D417/06 , C07D471/04 , C07D498/04 , C07D513/04 , A61K31/416 , A61K31/428 , A61K31/538
Abstract: The invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I), wherein B, R1, R2 and n have the meanings given in the description, for combating diseases of addiction and other diseases of t he central nervous system.
-
19.
公开(公告)号:CA2368823C
公开(公告)日:2008-10-21
申请号:CA2368823
申请日:2000-04-28
Applicant: BASF AG
Inventor: GROSS GERHARD , STARCK DOROTHEA , TREIBER HANS-JORG , MUHLBAUER BERND
IPC: A61K31/506 , C07D241/04 , A61K31/00 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/517 , A61K31/5513 , A61K45/00 , A61P1/00 , A61P13/12 , C07D401/12 , C07D403/12
Abstract: The invention relates to the use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders.
-
20.
公开(公告)号:ZA200110044B
公开(公告)日:2003-03-06
申请号:ZA200110044
申请日:2001-12-06
Applicant: BASF AG
Inventor: BERND MUEHLBAUER , GROSS GERHARD , STARCK DOROTHEA , TREIBER HANS-JOERG
IPC: C07D241/04 , A61K31/00 , A61K31/472 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5513 , A61K45/00 , A61P1/00 , A61P13/12 , C07D401/12 , C07D403/12 , A61P , A61K
Abstract: The invention relates to the use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders.
-
-
-
-
-
-
-
-
-